Frequently Asked Questions About MLCL.CN

What does Molecule Holdings Inc. do?

Molecule Holdings Inc. (MLCL.CN) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is MLCL.CN's market cap?

Molecule Holdings Inc. (MLCL.CN) has a market capitalization of approximately $488,910, as of July 23, 2024, based on the most recent share price and shares outstanding.

Does MLCL.CN pay a dividend?

No — Molecule Holdings Inc. (MLCL.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is MLCL.CN profitable?

Molecule Holdings Inc. (MLCL.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

MLCL.CN (Molecule Holdings Inc.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

MLCL.CN

Molecule Holdings Inc.

CNQ·Drug Manufacturers, Specialty & Generic · Healthcare

C$0.01C$0.00+0.00%

Market capC$488.91K·Market closed·Jul 23 8:00 PM UTC

Price Chart

C$0.01+C$0.00 (+0.00%)today

−93.75%CAGR −42.60%

Select date range

FromTo

Sep 17, 2020Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

MLCL.CN does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 29

Last Report DateOct 26

Reported vs Estimate−C$0.01

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$1.78M

Net Income−C$3.83M

Net Margin−215.1%

Operating Cash Flow−C$98.67K

Capital ExpendituresC$7.00

Free Cash Flow−C$98.67K

Return on Equity—

Return on Invested Capital−118.6%

Net DebtC$5.69M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for MLCL.CN and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how MLCL.CN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MLCL.CN and 80,000+ other tickers.

About Molecule Holdings Inc.

Molecule Holdings Inc. is a Canadian enterprise specializing in the manufacturing and co-packaging of cannabis-infused beverages. The company markets its range of drinks through the PHRESH, embody, and CANAJO brand names. Its corporate headquarters are located in Lansdowne, Canada.

CEO: David Reingold
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: CNQ
Website: www.molecule.ca

Peers

Peers Tab

GHG.CN

Global Hemp Group Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About MLCL.CN

What does Molecule Holdings Inc. do?: Molecule Holdings Inc. (MLCL.CN) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is MLCL.CN's market cap?: Molecule Holdings Inc. (MLCL.CN) has a market capitalization of approximately $488,910, as of July 23, 2024, based on the most recent share price and shares outstanding.
Does MLCL.CN pay a dividend?: No — Molecule Holdings Inc. (MLCL.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is MLCL.CN profitable?: Molecule Holdings Inc. (MLCL.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.